Detalles de la búsqueda
1.
The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer.
Tumour Biol
; 35(1): 701-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23955802
2.
The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Ann Surg Oncol
; 20(13): 4305-11, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23892527
3.
Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4.
Nat Genet
; 31(4): 395-9, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12118254
4.
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
Chin J Cancer
; 29(7): 641-8, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20591215
5.
[Antitumor response induced by vaccine of autologous dendritic/tumor fusion cells against renal cell].
Zhonghua Zhong Liu Za Zhi
; 29(6): 411-4, 2007 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-17974271
6.
[Loss of heterozygosity in the region of chromosome 4p15.1-4q12 in nasopharyngeal carcinoma patients with familial history].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
; 24(2): 189-91, 2007 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-17407079
7.
Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
Cancer Genet Cytogenet
; 166(2): 166-72, 2006 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16631475
8.
Identification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity.
World J Gastroenterol
; 12(15): 2437-40, 2006 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-16688840
9.
Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
Oncotarget
; 7(13): 16248-61, 2016 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26919247
10.
Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China).
Eur J Hum Genet
; 13(2): 248-52, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15483644
11.
Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.
Oncoimmunology
; 4(9): e1038017, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26405607
12.
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
Oncoimmunology
; 4(2): e976507, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25949875
13.
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
Sci Rep
; 5: 9202, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25776856
14.
Genetic polymorphisms of CYP2A13 and its relationship to nasopharyngeal carcinoma in the Cantonese population.
J Transl Med
; 2(1): 24, 2004 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15222883
15.
The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China.
Cancer Lett
; 176(1): 65-73, 2002 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-11790455
16.
Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
Clin Cancer Res
; 20(11): 3003-11, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24668644
17.
Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
PLoS One
; 7(7): e40364, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22808142
18.
Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients.
Int J Biol Sci
; 7(1): 53-60, 2011 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21234303
19.
[Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
Ai Zheng
; 27(7): 685-91, 2008 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-18606059
20.
Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.
J Immunother
; 31(1): 63-71, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18157013